United States
China
India
Japan
Singapore
South Africa
United Kingdom
As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
Journals
1-147 of 4,900+ results.
Access the full Coronavirus Research Archive
- research-articleMyocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations
- otherUnderstanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19
- research-articleImmunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
- research-articleEffectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
- research-articleThe detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19
- research-articleA serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?
- review-articleRegistered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
- research-articleEvaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019
- research-articleThe (apparent) antibody paradox in COVID-19
- research-articlePost-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study
- research-articleTocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence
- review-articleTherapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?
- article-commentaryStrategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
- research-articleBamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
- review-articleEmerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
- research-articleCurrent and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)
Books
- research-articleSARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
- research-articleCOVID-19 transmission risk factors
- review-articleVitamin D and COVID-19: where are we now?
- research-articleAntibody levels remain high to one-year’s follow-up after moderate and severe COVID-19, but not after mild cases
- research-articleHydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study
- research-articleConvalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
- review-articleExploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
- research-articleInhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
- otherPoint-of-care COVID-19 testing in the emergency department: current status and future prospects
- research-articleCorrespondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
- research-articleAssessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study
- research-articleCOVID-19 vaccine equity: a health systems and policy perspective
- research-articleRole of hemagglutinin esterase in replication of SARS-CoV-2
- research-articleAnaemia and enhancement of coagulation are associated with severe COVID-19 infection
- research-articleCelecoxib, Glipizide, Lapatinib, and Sitagliptin as potential suspects of aggravating SARS-CoV-2 (COVID-19) infection: a computational approach
- research-articleThe role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types
- research-articleImmunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
- otherResponse to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19
- otherIndomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19
- research-articleFerritin as prognostic marker in COVID-19: the FerVid study
- research-articleThe clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center
- research-articleTherapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins
- research-articleHigh rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients
- research-articleIdentification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2
- research-articleLower plasma calcium associated with COVID-19, but not with disease severity: a two-centre retrospective cohort study
- otherTherapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
- research-articleInvestigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients
- research-articleCan Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?
- rapid-communicationDuplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS – CoV-2
- research-articleArjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies
- research-articleAntibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- research-articleDetection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition
- review-articleNuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment
- research-articleUnderstanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach